期刊文献+

前列腺素E_1对肺心病病人血流动力学参数及血气分析的影响 被引量:4

EFFECTS OF PROSTAGLANDIN E_1 ON HEMODYNAMICS AND BLOOD GAS IN PATIENTS WITH COR PULMONALE
下载PDF
导出
摘要 ①目的观察前列腺素E1(PGE1)对肺心病病人肺动脉高压血流动力学参数及动脉血氧分压影响.②方法将我院2001年6月~2004年12月的肺心病住院病人分成2组,治疗组59例,对照组25例.两组均对基础疾病进行常规治疗,而治疗组在此基础上加用PGE1 40 μg+生理盐水20 mL,每日2次静脉推注(5 ng·kg-1·min-1),共7 d.记录病人治疗前、后的超声检查结果及血气分析指标.③结果治疗后治疗组肺动脉收缩压(PASP)、肺血管阻力(PVR)、右心房内径(RA)、右心室内径(RV)下降明显(t=2.08~3.14,P<0.05);而左心室射血分数(LVEF)、心排血量(CO)显著升高(t=2.73、3.04,P<0.05);血氧分压(PaO2)及氧饱和度(SO2)有一定程度的下降,但差异无显著性.治疗组PASP、PVR下降较对照组明显(t=3.24、2.46,P<0.05);PaO2及SO2有所下降,但差异无显著性.将治疗组病人按肺气肿类型分为支气管炎(BB)型和气肿(PP)型两类,两型在PGE1治疗后血流动力学状态均有改善,但PP型PaO2及SO2无明显下降,而BB型却下降较明显,两者差异有显著性(t=2.54、2.50,P<0.05).④结论PGE1可显著降低肺心病病人的PASP和PVR,且对病人的PaO2及SO2有一定的影响,但如果病人的肺气肿类型为BB型,则对PaO2及SO2基本无影响. Objective To investigate the effects of prostaglandin E1 (PGEl)on hemodynamics and blood gas analysis in patients with cor pulmonale. Methods Patients with cot pulmonale were randomly divided into treated group (n=59) and control group (n= 25). A routine therapy was given to underlying diseases of all the patients. Beside the routine treatment, patients in the treated group were given PGE1 40/μg+20 mL NS, iv, Bid× 7 d (rate of infusion; 5 ng· kg^-1 · min^-1). An echocardiography and blood gas analysis were recorded before and after treatment. Results After the treatment, those in the treated group achieved significant decrease of pulmonary artery systolic pressure (PASP), pulmonary vascular resistance (PVR), internal diameter of right atrium/ventricle, but significant increase of left ventricular ejection fraction (LVEF) and cardiac output (CO). The PaO2 and SO2 decreased, but not significantly. Compared with the control group, PASP and PVR improved significantly. According to emphysema type, the patients in the treated group were subdivided into pink puffer (PP) group and blue bloater (BB) group, both improved in hemodynamics after using PGE1. Compared with the PP group, the PaO2 and SO2 of BB group had a significant decrease. Conclusion PGE1 can significantly decrease the PASP and PVR of patients with cor pulmonale, and has some effect on PaO2 and SO2, but has little effect on PaO2 and SO2 of the patients with PP emphvsema.
出处 《齐鲁医学杂志》 2005年第4期306-307,309,共3页 Medical Journal of Qilu
关键词 肺心病 前列地尔 超声心动描记术 血气分析 pulmonary heart disease alprostadil echocardiography blood gas analysis
  • 相关文献

参考文献8

  • 1Shen JY, Chen SL , Wu YX, et al. Pulmonary hypertension in systemic lupus erythematosus [J]. Rheumatol Int, 1999,18:147.
  • 2Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxia and cor pulmonale complicating chronic bronchitis and emphysema [J]. Lancet,1981,1:681.
  • 3Naeije R, Melot C, Mols P, et al. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease [J]. Am Rev Respir Dis, 1982,125:1.
  • 4Szczeklick J. Effects of Prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertrnsion [J]. Br Heart J,1987, 40: 1397.
  • 5Winslow TM, Ossipov MA, Fazio GP, et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus [J]. Am Heart J, 1995, 129: 510.
  • 6Heerdt PM, Weiss CI. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension[J]. Ann Thorac Surg, 1990, 49: 463.
  • 7Kawahara R, Takezawa J, Mike N, et al. Prostaglandin E1 in pulmonary hypertension of collagen disease [J]. Crit Care Med, 1987 ,15:884.
  • 8Kermode J, Butt W, Shann F. Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery [J]. Br Heart J, 1991, 66:175.

同被引文献33

  • 1杨玉敏,王文统,石玲燕,周剑宇.前列地尔脂微球载体制剂治疗肺心病心衰及对肺动脉压力的影响[J].中国基层医药,2004,11(6):757-758. 被引量:2
  • 2朱元钰,陈文彬.呼吸病学[M].北京:人民卫生出版社,2006.
  • 3陈灏珠.实用内科学[M].北京:人民卫生出版社,1973:585.
  • 4陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 5BANDARA M, GORDON F D, SARWAR A, et al. Success- ful outcomes following living donor liver transplanthtion for portopulmonary hypertension[J]. Liver Transpl, 2010,16(8) : 983-989.
  • 6GIUSCA S, JINGA M, JURCUT C, et al. Portopulmonaryhypertension: from diagnosis to treatment[J]. Eur J Intern Med, 2011,22(5) :441-4,47.
  • 7KROWKA M J. Portopulmonary hypertension[J] Semin Re- spir Crit Care Med, 2012,33(1):17-25.
  • 8LU A W, HUANG D S, ZHENG S S, et al. The changes o{ hemodynamics in peri-operative period of orthotopic liver transplantation in patients with chornic hepatic diseases[J]. Journal o[ Zheiiang University Medical Sciences, 2001,30(6) : 245-247.
  • 9TAN H P, MARKOWITZ J S, MONTGOMERY R A, et al. Liver transplantatinn in patients with sevre portnpulmnnary hypertension treated with preoperative chronic intravenous epoprostenol[J]. Liver Transpl, 2001,7 745-749.
  • 10KEEGAN M T, KAMATH G S, VASDFV G M, et al. laver transplantation for masive hepatic haemangiomatosis causing restrictive lung disease[J]. Br J Anaesth, 2001,86:431 434.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部